Bivalent mRNA vaccines against three SARS-CoV-2 variants mediated by new ionizable lipid nanoparticles

[Display omitted] Lipid nanoparticles (LNPs)-based mRNA vaccines have shown great potential in the fight against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. However, it remains still a challenge to improve the delivery efficiency of LNPs and the long-term stability of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of pharmaceutics 2023-07, Vol.642, p.123155-123155, Article 123155
Hauptverfasser:	Wang, Ji, Zhang, Yanhao, Dong, Shuo, Zha, Wenhui, Liu, Chao, Wang, Yang, Jiang, Yuhao, Xing, Hanlei, Li, Xinsong
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Viral BNT162 Vaccine COVID-19 - prevention & control Decanoates Esters Humans Ionizable lipid mRNA vaccine mRNA Vaccines Nanoparticles SARS-CoV-2 SARS-CoV-2 - genetics Thermostability Vaccines, Combined Variant
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!